Swaraj Shares and Securities Private Limited ("Manager to the Offer") has submitted to BSE a copy of Post-Offer Public Announcement to the Public Shareholders of Chemo Pharma Laboratories ....

Open offer triggeredListed-company acquisitionStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹119.35

prior close

₹117.55

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.8%+0.3% vs market

Pharmaceuticals peers, median of 151sector-1.7%+0.2% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5-1.8+0.3-1.7+0.2

Next day

—-1.5—-1.0—

-1.5-1.3-0.2-1.2-0.4

+0.5-0.8+1.2-0.9+1.4

-1.5+1.1-2.6+0.3-1.8

-3.2+1.1-4.4+0.2-3.5

-2.0+2.5-4.5+1.3-3.3

15d

+3.9+3.2+0.8+1.9+2.1

+7.2+4.1+3.1+3.4+3.7

+11.4+0.5+10.9-0.1+11.5

+3.9+2.8+1.1+0.9+3.0

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Manager to the Offer Swaraj Shares & Securities has submitted to BSE the Post-Offer Public Announcement for an open offer made by Atibha Agriseeds Private Limited (Acquirer) to acquire up to 3,90,000 shares (26.00% of voting share capital) from public shareholders of Chemo Pharma Laboratories Limited at an offer price of ₹110 per share, aggregating to ₹4.29 crore. The offer was triggered under SEBI (SAST) Regulations pursuant to a Share Purchase Agreement dated February 18, 2025, under which the Acquirer bought 4,18,281 shares (27.89%) from promoters Citric India Limited and Shanta Somani at ₹100 per share. The Post-Offer Advertisement was published on June 19, 2025, in Financial Express, Jansatta, and Mumbai Lakshadeep newspapers.

Likely market impact

Public shareholders of Chemo Pharma Laboratories now have clarity on the concluded open offer timeline and pricing; the offer price of ₹110 represents a 10% premium over the underlying SPA price of ₹100 paid to promoters, indicating the minimum exit opportunity offered to public investors.